Daniela Rau
Ulm, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Implementing the 2024 revision of the McDonald diagnostic criteria for multiple sclerosis in Germany: Practical considerations and consensus recommendations.
Journal: Therapeutic advances in neurological disorders
Published: May 18, 2026
First insights into the safety and effectiveness of additional courses with cladribine tablets under real-world conditions.
Journal: Multiple sclerosis and related disorders
Published: December 04, 2024
Real-world therapy management of patients with multiple sclerosis receiving cladribine tablets beyond year 4 - Results from a German cladribine cohort.
Journal: Multiple sclerosis and related disorders
Published: April 11, 2024
Evaluation of Patient-Reported Outcomes in Patients with Relapsing Multiple Sclerosis Treated with Cladribine Tablets in the CLAWIR Study: 12-Month Interim Analysis.
Journal: Advances in therapy
Published: July 24, 2023
Assessment of the treating physicians' first-hand experience with handling and satisfaction of ofatumumab therapy: findings from the PERITIA survey conducted in Europe.
Journal: BMC neurology
Published: February 28, 2022
An ID-Associated Application to Facilitate Patient-Tailored Management of Multiple Sclerosis.
Journal: Brain sciences
Published: July 15, 2021
Oral pulsed therapy of relapsing multiple sclerosis with cladribine tablets - expert opinion on issues in clinical practice.
Journal: Multiple sclerosis and related disorders
Published: May 07, 2021
Mental symptoms in MS (MeSyMS): Development and validation of a new assessment.
Journal: Multiple sclerosis and related disorders
Published: October 11, 2020
Listeria Meningitis Complicating Alemtuzumab Treatment in Multiple Sclerosis--Report of Two Cases.
Journal: International journal of molecular sciences
Published: June 04, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026